Opinion in Asia-Pacific

Published within

« | ... | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

Aldi courts the green market with adoption of carbon label program

Last month, grocery retailer Aldi became the first retailer in Australia to launch a carbon footprint label in its stores, introducing an everyday olive oil range that features a Carbon Reduction Label. The launch will appeal to the growing number of environmentally conscious Australians, but competing environmental and ethical claims may impact upon its success.

Published By Datamonitor
09 Nov 2010
CommentWire
CommentWire

Aldi: aggressive expansion in Australia through profit reinvestment

In the wake of improved net profits in 2009, Aldi has announced further investment in its Australian infrastructure and stores. Investing in the market will enable the discounter to boost market share, and help to reduce the dominance of Woolworths and Coles. Furthermore, Verdict research shows that Australian consumers are particularly responsive to Aldi's core proposition: private label.

Published By Datamonitor
14 Sep 2010
CommentWire
CommentWire

Alinta: driving growth and diversification through acquisition

The price may be high, but for Alinta [ALN.AX] it is worth paying Duke [DUK] A$1.69 billion to capture some of Australia's most important gas pipelines, as well as power generation assets. Capitalizing on US energy companies' steady exit from Australia, the company is both improving the diversity of its operations and creating steady long-term growth in shareholder returns.

Published By Datamonitor
18 Mar 2004
Expert View
Expert View

Alipay poised for global acceptance

The strength of the Chinese e-commerce market is pushing e-tailers around the world to accept Alipay, which will eat into the market share of established online payments players.

Published By Datamonitor
18 Sep 2014
Expert View
Expert View

All change in the offshore market

The performance of offshore centers around the globe has varied enormously in recent years. While some hubs have thrived, others have struggled due to increasing regulation and changing client needs.

Published By Datamonitor
08 Oct 2014
CommentWire
CommentWire

Alliance Boots: first steps into China

With strong economic growth, changing demographic patterns, and the reform and expansion of health care systems, China is an attractive market for Alliance Boots. The investment vehicle formed to acquire the 50% share in Guangzhou Pharmaceuticals Corporation, one of China's leading wholesalers, will provide a platform for further expansion.

Published By Datamonitor
29 Jan 2007
CommentWire
CommentWire

Allianz: another entrant into burgeoning Islamic insurance sector

Global insurance giant Allianz is to launch a range of Shariah law-compliant services in southeast Asia as it looks to take advantage of the growing demand for the religiously and ethically sensitive products. With awareness of the new Takaful insurance sector taking-off, those who can get in early are almost certainly in line to prosper.

Published By Datamonitor
26 Jan 2006
CommentWire
CommentWire

Alstom: super critical technology provides bright spot

Tying up with local player BHEL is the right strategy for Alstom in India. It spreads the Indian power sector's political and market risk with a local company that is well poised to win the major super critical power plant contracts that are on the horizon.

Published By Datamonitor
24 Mar 2003
Expert View
Expert View

Alternative investments to flourish in Hong Kong

Measures proposed by the Hong Kong government to develop the country's alternative asset industry are expected to drive demand for hedge funds and private equity, meaning wealth managers should position their product and service offerings accordingly.

Published By Datamonitor
08 Mar 2013
CommentWire
CommentWire

Amarin: RNA therapy results announced to attract suitors

In an effort to generate interest from potential partners in its investigational myasthenia gravis agent, EN101, Amarin has announced positive final efficacy data from an exploratory Phase IIa study. Although these promising data support a symptomatic effect, greater value could be expected if immunosuppressant activity is also demonstrated in later trials.

Published By Datamonitor
11 Jun 2009

« | ... | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ... | » »|

No help is available.